Society for Maternal-Fetal Medicine Consult Series #51: Thromboembolism prophylaxis for cesarean delivery
- PMID: 32360109
- DOI: 10.1016/j.ajog.2020.04.032
Society for Maternal-Fetal Medicine Consult Series #51: Thromboembolism prophylaxis for cesarean delivery
Abstract
Venous thromboembolism is a major cause of maternal morbidity and mortality. The risk of venous thromboembolism is particularly elevated during the postpartum period and especially after cesarean delivery. There is considerable variation in the approach to prophylaxis of venous thromboembolism in pregnancy, including after cesarean delivery. This Consult discusses the different guidelines on prophylaxis of venous thromboembolism after cesarean delivery and provides recommendations based on the available evidence. The recommendations by the Society for Maternal-Fetal Medicine are as follows: (1) we recommend that all women who undergo cesarean delivery receive sequential compression devices starting before surgery and that the compression devices be used continuously until the patient is fully ambulatory (GRADE 1C); (2) we suggest that women with a previous personal history of deep venous thrombosis or pulmonary embolism who undergo cesarean delivery receive both mechanical (starting preoperatively and continuing until ambulatory) and pharmacologic (for 6 weeks postoperatively) prophylaxis (GRADE 2C); (3) we suggest that women with a personal history of an inherited thrombophilia (high-risk or low-risk) but no previous thrombosis who undergo cesarean delivery receive both mechanical (starting preoperatively and continuing until ambulatory) and pharmacologic (for 6 weeks postoperatively) prophylaxis (GRADE 2C); (4) we recommend the use of low-molecular-weight heparin as the preferred thromboprophylactic agent in pregnancy and the postpartum period (GRADE 1C); (5) when pharmacologic thromboprophylaxis is needed in pregnant women with class III obesity, we suggest the use of intermediate doses of enoxaparin (GRADE 2C); and (6) we recommend that each institution develop a patient safety bundle with an institutional protocol for venous thromboembolism prophylaxis among women who undergo cesarean delivery (Best Practice).
Keywords: cesarean delivery; maternal morbidity; maternal mortality; prophylaxis of venous thromboembolism; venous thromboembolism.
Copyright © 2020. Published by Elsevier Inc.
Comment in
-
Society for Maternal-Fetal Medicine Consult Series #51: thromboembolism prophylaxis for cesarean delivery.Am J Obstet Gynecol. 2021 Feb;224(2):243-244. doi: 10.1016/j.ajog.2020.09.033. Epub 2020 Sep 24. Am J Obstet Gynecol. 2021. PMID: 32980355 No abstract available.
-
Reply.Am J Obstet Gynecol. 2021 Feb;224(2):244. doi: 10.1016/j.ajog.2020.09.034. Epub 2020 Sep 24. Am J Obstet Gynecol. 2021. PMID: 32980359 No abstract available.
-
Thromboprophylaxis following cesarean in women with class III obesity: a proposed alternative dosing regimen.Am J Obstet Gynecol. 2021 Apr;224(4):415-416. doi: 10.1016/j.ajog.2020.12.003. Epub 2020 Dec 8. Am J Obstet Gynecol. 2021. PMID: 33306973 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical